Latest market price
30.71
+0.89+2.98%
MDQT86Pediatrix Medical Group, Inc.·NYSE
30.71+2.98%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E16.69EPS (ttm)1.84Insider Own8.39%Shs Outstand81.25MPerf Week5.75%
Market Cap2.50BForward P/E12.38EPS next Y2.48Insider Trans-0.53%Shs Float79.96MPerf Month18.25%
Enterprise Value2.67BPEG—EPS next Q0.60Short Float5.47%Perf Quarter24.28%
Income151.00MP/S1.27EPS this Y15.37%Short Ratio5.85Perf Half Y37.04%
Sales1.96BP/B2.94EPS next Y3.18%ROA7.02%Short Interest4.37MPerf YTD43.57%
Book/sh10.46P/C5.86EPS next 5Y-2.78%ROE17.28%52W High31.07 -1.16%Perf Year76.60%
Cash/sh5.24P/FCF11.88EPS past 3/5Y34.91% —ROIC9.18%52W Low16.90 81.72%Perf 3Y164.06%
Dividend Est.—EV/EBITDA10.72Sales past 3/5Y-0.99% 1.99%Gross Margin25.83%Volatility3.98% 3.15%Perf 5Y13.83%
Dividend TTM—EV/Sales1.36EPS Y/Y TTM-2.13%Oper. Margin11.40%ATR (14)0.94Perf 10Y-53.83%
Dividend Ex-Date—Quick Ratio1.28Sales Y/Y TTM1.93%Profit Margin7.66%RSI (14)76.14Recom2.67
Dividend Gr. 3/5Y—Current Ratio1.28EPS Q/Q7.46%SMA209.82%Beta0.59Target Price26.60
Payout0.00%Debt/Eq0.71Sales Q/Q1.62%SMA5013.67%Rel Volume1.54Prev Close29.82
Employees4,280LT Debt/Eq0.50EarningsFeb 18SMA20028.45%Avg Volume758.11KPrice30.71
IPO DateSep 20, 1995Option/ShortYes / YesEPS/Sales Surpr.10.82% 0.64%Net Debt/EBITDA0.70Volume1,171,044Change2.98%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-19-26DowngradeJefferiesBuy → Hold$27 → $28
Aug-06-26ReiteratedUBSNeutral$25 → $28
Aug-05-26ReiteratedDeutsche BankHold$19 → $25
Jul-14-26ReiteratedTruist SecuritiesHold$21 → $28
May-12-26ReiteratedUBSNeutral$22 → $25
May-08-26ReiteratedMizuho SecuritiesNeutral$21 → $24
Apr-20-26ReiteratedJefferiesBuy$24 → $27
Feb-24-26ReiteratedUBSNeutral$23 → $22
Feb-20-26ReiteratedDeutsche BankHold$21 → $19
Nov-10-25ReiteratedTruist SecuritiesHold$17 → $24
Latest News· Times ET
Oct-30-26
Oct-29-26
Oct-24-26
Oct-20-26
Oct-14-26
Oct-09-26
Oct-06-26
Oct-01-26
Sep-30-26
Sep-22-26
Sep-18-26
Sep-16-26
Sep-15-26
Company

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue1,9591,9142,0131,995—————
Cost of Goods Sold Incl. D&A1,4521,4421,5591,573—————
Gross Profit505472454422—————
Selling, General and Administrative Excl. Other250241238228—————
Research and Development
0000—————
Other Operating Expense330285186—————
Operating Income224231-697—————
Interest Expense33364142—————
Unusual Expense
—————————
Non-Operating Income (Expense)14218-14—————
Net Income Before Taxes204216-101-48—————
Income Taxes5351-212—————
Consolidated Net Income151165-99-60—————
Net Income From Continuing Operations151165-99-60—————
Net Income151165-99-60—————
EPS (Recurring)1.871.94-1.19-0.73—————
EPS (Basic, Before Extraordinaries)1.871.94-1.19-0.73—————
EPS (Diluted)1.841.94-1.19-0.73—————
EBITDA249274-2830—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio16.6911.03———————
Price To Sales Ratio1.210.950.540.38—————
Gross Margin25.7824.6622.5521.15—————
Operating Margin11.4312.07-3.430.35—————
Net Margin7.718.62-4.92-3.01—————
Shares Outstanding77858382—————
Market Capitalization2,3651,8181,089763—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$32.95$28.10$23.26$18.41$13.56● Close Price0.00K213.92K427.83K641.75K855.66KUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Weis Shirley ADirectorMay 13 '26Sale23.7536,028855,6650May 14
ORDAN MARK SChief Executive OfficerDec 15 '25Sale22.4123,000515,430302,805Dec 17
Rucker Michael A.DirectorNov 17 '25Sale23.0010,478240,99459,101Nov 19
Linynsky Laura ADirectorNov 06 '25Sale21.6510,000216,50032,232Nov 10
ORDAN MARK SDirectorNov 13 '24Sale15.3527,600423,660138,683Nov 14
Moore Mary Ann EEVP, GC, Chief Admin Off & SecNov 08 '24Sale16.008,108129,728135,810Nov 12
Swift James DChief Executive OfficerAug 30 '24Sale10.7911,100119,769170,001Sep 03
Linynsky Laura ADirectorAug 27 '24Sale11.167,00078,12030,805Aug 29
Richards C MarcEVP, Chief Financial OfficerAug 12 '24Sale10.0817,438175,775175,347Aug 13
Richards C MarcEVP, Chief Financial OfficerAug 09 '24Sale10.0832,562328,225192,785Aug 13
Moore Mary Ann EEVP, General Counsel & SecDec 14 '23Sale9.622,12020,39415,730Dec 15
Swift James DChief Executive OfficerDec 14 '23Sale9.585,76455,21990,874Dec 15
Swift James DChief Executive OfficerJun 14 '23Sale14.1413,193186,54996,638Jun 16
ORDAN MARK SDirectorMay 25 '23Sale13.2633,000437,580147,923May 26
Weis Shirley ADirectorMay 19 '23Sale13.631,00713,72517,668May 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.